|
|
|
|
Structural and Genetic Studies Demonstrate Neurologic Dysfunction in Triosephosphate Isomerase Deficiency Is Associated with Impaired Synaptic Vesicle Dynamics
|
|
|
|
|
|
|
|
نویسنده
|
roland b.p. ,zeccola a.m. ,larsen s.b. ,amrich c.g. ,talsma a.d. ,stuchul k.a. ,heroux a. ,levitan e.s. ,vandemark a.p. ,palladino m.j.
|
|
منبع
|
plos genetics - 2016 - دوره : 12 - شماره : 3
|
|
چکیده
|
Triosephosphate isomerase (tpi) deficiency is a poorly understood disease characterized by hemolytic anemia,cardiomyopathy,neurologic dysfunction,and early death. tpi deficiency is one of a group of diseases known as glycolytic enzymopathies,but is unique for its severe patient neuropathology and early mortality. the disease is caused by missense mutations and dysfunction in the glycolytic enzyme,tpi. previous studies have detailed structural and catalytic changes elicited by disease-associated tpi substitutions,and samples of patient erythrocytes have yielded insight into patient hemolytic anemia; however,the neuropathophysiology of this disease remains a mystery. this study combines structural,biochemical,and genetic approaches to demonstrate that perturbations of the tpi dimer interface are sufficient to elicit tpi deficiency neuropathogenesis. the present study demonstrates that neurologic dysfunction resulting from tpi deficiency is characterized by synaptic vesicle dysfunction,and can be attenuated with catalytically inactive tpi. collectively,our findings are the first to identify,to our knowledge,a functional synaptic defect in tpi deficiency derived from molecular changes in the tpi dimer interface. © 2016,public library of science. all rights reserved.
|
|
|
|
|
آدرس
|
department of pharmacology & chemical biology,university of pittsburgh school of medicine,pittsburgh,pa,united states,the pittsburgh institute for neurodegenerative diseases (pind),university of pittsburgh school of medicine,pittsburgh,pa,united states,department of biological sciences,vanderbilt university,nashville,tn, United States, department of pharmacology & chemical biology,university of pittsburgh school of medicine,pittsburgh,pa,united states,the pittsburgh institute for neurodegenerative diseases (pind),university of pittsburgh school of medicine,pittsburgh,pa, United States, department of pharmacology & chemical biology,university of pittsburgh school of medicine,pittsburgh,pa,united states,the pittsburgh institute for neurodegenerative diseases (pind),university of pittsburgh school of medicine,pittsburgh,pa, United States, department of biological sciences,university of pittsburgh,pittsburgh,pa, United States, department of pharmacology & chemical biology,university of pittsburgh school of medicine,pittsburgh,pa,united states,the pittsburgh institute for neurodegenerative diseases (pind),university of pittsburgh school of medicine,pittsburgh,pa, United States, department of pharmacology & chemical biology,university of pittsburgh school of medicine,pittsburgh,pa,united states,the pittsburgh institute for neurodegenerative diseases (pind),university of pittsburgh school of medicine,pittsburgh,pa, United States, energy sciences directorate/photon science division,brookhaven national laboratory,upton,ny, United States, department of pharmacology & chemical biology,university of pittsburgh school of medicine,pittsburgh,pa, United States, department of biological sciences,university of pittsburgh,pittsburgh,pa, United States, department of pharmacology & chemical biology,university of pittsburgh school of medicine,pittsburgh,pa,united states,the pittsburgh institute for neurodegenerative diseases (pind),university of pittsburgh school of medicine,pittsburgh,pa, United States
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|